VF in the News

New VF Board Member Jacquelyn Eidson Hopes to Advocate for Rural Patients

Author: Nina Silberstein Jacquelyn (Jacque) Eidson wanted to serve on the VF Board of Directors because she knows firsthand the impact that vasculitis has on patients, and those who love them. Jacque’s father-in-law was diagnosed with vasculitis nearly 15 years ago and she believes his medical journey was much different…...

Read more

FDA Approves Otezla®for the Treatment of Oral Ulcers in Behcet’s Disease

Celgene Corporation announced on July 19 that the U.S. Food and Drug Administration (FDA) has approved Otezla® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behcet’s disease. Otezla, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only…...

Read more

Dr. Sebastian E. Sattui Receives 2019 VCRC-VF Fellowship Award

Sebastian Sattui, MD It was during a medical clerkship that Sebastian Sattui, MD, first recognized the complexity of vasculitis, and the profound impact the disease has on patients’ lives. He had encountered a patient with EGPA (eosinophilic granulomatosis with polyangiitis) for the first time. “I will always remember the patient’s…...

Read more